Spain-Valladolid: General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Full title
Spain-Valladolid: General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
España-Valladolid: Antiinfecciosos generales para uso sistémico, vacunas, antineoplásicos e inmunomoduladores · Original title, Spanish
Buyer: Consejería de Sanidad de la Junta de Castilla y León
Awarded to: not read by DefenceGate: winners are read for the notices of the defence core scope, and this notice is listed for its buyer only; the original notice names them
- Filed under the defence procurement directive by a civil buyer
- Municipal body
Listed by our automatic rules, with how sure we are estimated from checked samples; see how
The notice states the defence procurement directive as its legal basis, and nothing else marks it as defence: its buyer is not a defence or security body. It is listed with supplies, not with defence notices.
Key facts
- Value in the award notice
- EUR 6,849,810The total the award notice states; not told apart as a contract value or a framework ceiling
- Notice ID
- 249202-2018
- Published
- Procedure
- Award without prior publication of a contract notice
- Legal basis
- Directive 2009/81/EC (defence and security procurement)Code 32009L0081
- Buyer country
- ESSpain
- Security clearance
- Not read from this source
- Subcontracting
- Not read from this source
- Status read from the notice
- Awarded
Who may bid
Directive 2009/81/EC (defence and security procurement)
Each EU country decides whether its buyers may let companies from outside the EU take part (recital 18): the notice says what applies. The buyer may ask, or its country may require it to ask, the winner to subcontract a share of the contract, at most 30 % of its value, to subcontractors it chooses by competition (Article 21): a way to take part in the work without bidding.
What the act says, not advice: the notice and the buyer set the conditions.
Who wins such contracts in SpainCPV codes
- 33650000MainGeneral anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
- 33651600Vaccines
Version history
One version observed so far, and 1 correction by DefenceGate (below).
What counts as a new version
We keep a new version when the title, buyer, country, procedure, legal basis, value, currency, publication date, deadline, product codes, source link or status changes. Earlier versions are never overwritten or deleted. History starts when we first saw the notice; our archive began in September 2026.
- Version 1 · Detected First observed by DefenceGate
- Corrected 12 Oct 2026: Procedure Award without prior publication of a contract notice added; Estimated value EUR 6,849,810 added; Currency EUR added; Published 4 Jun 2018 to 9 Jun 2018; Status Open to Awarded
1 correction by DefenceGate, not changes by the publisher
- Version 2 · Corrected by DefenceGate on We read the notice we already held again with a corrected reading: the publisher did not change it on this date, and it is not counted as a change.
- Procedure added: Award without prior publication of a contract notice
- Estimated value added: EUR 6,849,810
- Currency added: EUR
- Published changed from 4 Jun 2018 to 9 Jun 2018
- Status changed from Open to Awarded
Source and attribution
- Source
- Tenders Electronic Daily
- First seen by us
- Source last collected
- Licence
- Commission Decision 2011/833/EU; notices freely reusable incl. commercial
- Attribution
- Source: TED (Tenders Electronic Daily), © European Union